Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Christian Morath, Anita Schmitt, Michael Schmitt , Lei Wang , Christian Kleist , Gerhard Opelz , Caner Süsal , T Hien Tran , Sabine Scherer , Vedat Schwenger , Stephan Kemmner , Michael Fischereder , Manfred Stangl , Ingeborg A Hauser , Claudia Sommerer , Christian Nusshag , Florian Kälble , Claudius Speer , Louise Benning , Christian Bischofs , Sandra Sauer , Maria-Luisa Schubert , Alexander K

Journal title: BMJ Open

Journal number: Volume 12, Issue 11

Journal publisher: BMJ Publishing Group

Published year: 2022

Published pages: e066128

DOI identifier: 10.1136/bmjopen-2022-066128

ISSN: 2044-6055